General Archives - Page 2 of 2367

2 minute read

Reddit Stock Down 12% In 5 Days — Redditors Anticipate Consolidation Before ‘Next Wave Hits Early July’

June 20, 11:40 AM

Reddit stock (NYSE:RDDT) down 12.13% in past 5 days, closing at $60.21. Redditors discuss future prospects and potential for rebound in July.

RDDT

1 minute read

Cheche Group Rides High With NIO Partnership, Eyes Expansion: Details

By Nabaparna Bhattacharya

June 20, 10:35 AM

Cheche Group's NEV insurance prospects soar with NIO partnership, aiming to revolutionize digital insurance management in China's EV market.

CCG

1 minute read

Tesla’s Top Rival, BYD’s Yuan Family Hits 1M Sales Milestone As SUV Lineup Drives NEV Success: Report

By Nabaparna Bhattacharya

June 20, 10:33 AM

BYD's Yuan family achieves 1 million sales milestone, highlighting success in NEV market with SUV lineup, amidst ongoing model expansions.

BYDDF

2 minute read

PTC Therapeutics Says FDA Lifts Clinical Hold On Investigational Study In Patients With Rare Weak Nerve Cell Disorder

By Vandana Singh

June 20, 10:09 AM

PTC Therapeutics released interim results from its Phase 2 PIVOT-HD study on PTC518 for Huntington's disease. The FDA has lifted the partial clinical hold on the program.

PTCT

2 minute read

Joby Aviation Opens Slightly Lower After FAA Gives Nod To Air-Taxi Software

By Benzinga Neuro

June 20, 10:03 AM

Joby Aviation intends to utilize ElevateOS for its air taxi operations and make it available to select partners who purchase their aircraft.

JOBY

2 minute read

Recreation Products Maker Winnebago Struggles In Q3 With Lower Earnings, But New Product Launches Offer Hope: Details

By Nabaparna Bhattacharya

June 20, 9:56 AM

Winnebago Industries shares drop post-Q3 earnings miss with lower revenues and decreased gross profit margins amid challenging market conditions.

WGO

2 minute read

What’s Going On With Cancer-Focused Tempest Therapeutics Stock On Thursday?

By Vandana Singh

June 20, 9:43 AM

Tempest Therapeutics shares drop 13% to $2.48 on Thursday despite promising new data from its Phase 1b/2 study. The study shows a six-month survival improvement in hepatocellular carcinoma patients using TPST-1120 combined with atezolizumab and bevacizumab.

TPST

2 minute read

Nvidia’s Rise Resembles Dot-Com Boom Era, But Former CISCO CEO Says Things Are ‘Different’ This Time

By Benzinga Neuro

June 20, 9:23 AM

John Chambers, who was the CEO of Cisco Systems Inc. when it otok the top spot at the height of the dot-com boom, noted parallels between the two periods

CSCO